全文获取类型
收费全文 | 4246篇 |
免费 | 234篇 |
国内免费 | 54篇 |
专业分类
耳鼻咽喉 | 14篇 |
儿科学 | 67篇 |
妇产科学 | 81篇 |
基础医学 | 495篇 |
口腔科学 | 64篇 |
临床医学 | 320篇 |
内科学 | 1446篇 |
皮肤病学 | 69篇 |
神经病学 | 504篇 |
特种医学 | 199篇 |
外科学 | 570篇 |
综合类 | 20篇 |
预防医学 | 114篇 |
眼科学 | 44篇 |
药学 | 198篇 |
中国医学 | 16篇 |
肿瘤学 | 313篇 |
出版年
2023年 | 33篇 |
2022年 | 72篇 |
2021年 | 119篇 |
2020年 | 87篇 |
2019年 | 93篇 |
2018年 | 132篇 |
2017年 | 110篇 |
2016年 | 126篇 |
2015年 | 132篇 |
2014年 | 186篇 |
2013年 | 260篇 |
2012年 | 357篇 |
2011年 | 340篇 |
2010年 | 211篇 |
2009年 | 195篇 |
2008年 | 289篇 |
2007年 | 281篇 |
2006年 | 257篇 |
2005年 | 298篇 |
2004年 | 259篇 |
2003年 | 189篇 |
2002年 | 157篇 |
2001年 | 23篇 |
2000年 | 16篇 |
1999年 | 25篇 |
1998年 | 22篇 |
1997年 | 29篇 |
1996年 | 25篇 |
1995年 | 26篇 |
1994年 | 14篇 |
1993年 | 10篇 |
1992年 | 14篇 |
1991年 | 19篇 |
1990年 | 16篇 |
1989年 | 12篇 |
1988年 | 15篇 |
1987年 | 5篇 |
1986年 | 7篇 |
1985年 | 7篇 |
1984年 | 12篇 |
1983年 | 3篇 |
1982年 | 5篇 |
1981年 | 9篇 |
1980年 | 4篇 |
1979年 | 3篇 |
1978年 | 3篇 |
1974年 | 4篇 |
1973年 | 3篇 |
1970年 | 4篇 |
1968年 | 2篇 |
排序方式: 共有4534条查询结果,搜索用时 15 毫秒
991.
The omega-3 fatty acid docosahexaenoate attenuates endothelial cyclooxygenase-2 induction through both NADP(H) oxidase and PKC epsilon inhibition 下载免费PDF全文
Massaro M Habib A Lubrano L Del Turco S Lazzerini G Bourcier T Weksler BB De Caterina R 《Proceedings of the National Academy of Sciences of the United States of America》2006,103(41):15184-15189
A high intake of the omega-3 fatty acid docosahexaenoate [docosahexaenoic acid (DHA)] has been associated with systemic antiinflammatory effects and cardiovascular protection. Cyclooxygenase (COX)-2 is responsible for the overproduction of prostaglandins (PG) at inflammatory sites, and its expression is increased in atheroma. We studied the effects of DHA on COX-2 expression and activity in human saphenous vein endothelial cells challenged with proinflammatory stimuli. A>or=24-h exposure to DHA reduced COX-2 expression and activity induced by IL-1, without affecting COX-1 expression. DHA effect depended on the NF-kappaB-binding site in the COX-2 promoter. EMSAs confirmed that DHA attenuated NF-kappaB activation. Because MAPK, PKC, and NAD(P)H oxidase all participate in IL-1-mediated COX-2 expression, we also tested whether these enzymes were involved in DHA effects. Western blots showed that DHA blocked nuclear p65 NF-kappaB subunit translocation by decreasing cytokine-stimulated reactive oxygen species and ERK1/2 activation by effects on both NAD(P)H oxidase and PKCepsilon activities. Finally, to address the question whether DHA itself or DHA-derived products were responsible for these effects, we inhibited the most important enzymes involved in polyunsaturated fatty acid metabolism, showing that 15-lipoxygenase-1 products mediate part of DHA effects. These studies provide a mechanistic basis for antiinflammatory and possibly plaque-stabilizing effects of DHA. 相似文献
992.
993.
Fahd Kandsi Fatima Zahra Lafdil Amine Elbouzidi Saliha Bouknana Achraf Miry Mohamed Addi Raffaele Conte Christophe Hano Nadia Gseyra 《Toxins》2022,14(7)
Dysphania ambrosioides (L.) Mosyakin and Clemants is a medicinal plant that has traditionally been used to cure a range of diseases. There has been no thorough investigation of the potential toxicity of this plant. The objective of this study is to assess the acute and subacute toxicity of D. ambrosioides hydroethanolic extract (DAHE), as well as it alkaloids composition, utilizing LC-MS/MS analysis. An in silico approach was applied to determine pharmacokinetic parameters and to predict the toxicity of D. ambrosioides identified alkaloids. A 14-day treatment with a single oral dose of 1–7 g/kg was carried out to investigate acute toxicity. DAHE was given orally at dosages of 5, 50, and 500 mg/kg for 15 days in the subacute toxicity investigation, and body weight and biochemical parameters were evaluated. Livers, kidneys, lungs, and heart were examined histologically. Chromatographic investigation revealed the existence of nine alkaloids, with N-formylnorgalanthamine being the most prevalent. The oral LD50 value of DAHE was found to be 5000 mg/kg in an acute toxicity study. No variations were observed with respect to food intake, water consumption, mortality, or body and organ weight in the subacute toxicity study. On the other hand, DAHE (500 mg/kg) significantly enhanced alanineaminotransferase, aspartate aminotransferase, and urea. Liver and kidney histological examinations revealed modest infiltration of hepatocyte trabeculae by inflammatory cells in the liver and slight alteration in the kidney histoarchitecture. According to our findings, DAHE exhibits low to moderate toxicity. 相似文献
994.
Celeste Manfredi Lorenzo Spirito Francesco Paolo Calace Raffaele Balsamo Marco Terribile Marco Stizzo Lorenzo Romano Luigi Napolitano Gianluigi Califano Luigi Cirillo Giovanni Maria Fusco Claudia Rosati Carmelo Quattrone Carmine Sciorio Massimiliano Creta Nicola Longo Marco De Sio Davide Arcaniolo 《Pathophysiology》2022,29(3):365
Intravesical chemotherapy may cause chemical cystitis and related lower urinary tract symptoms (LUTS). The aims of this study were to evaluate the efficacy and safety of an oral preparation of hyaluronic acid (HA), chondroitin sulfate (CS), curcumin, and quercetin (Ialuril® Soft Gels) to reduce the severity of LUTS in patients with a history of bladder cancer (BCa) undergoing intravesical chemotherapy. We designed a monocentric, randomized, double-blind, placebo-controlled pilot trial. Patients referred to our institute between November 2016 and March 2018 were enrolled. All subjects had non-muscle-invasive BCa and received intravesical chemotherapy with mitomycin C (MMC). Patients were randomized 1:1 in two groups (intervention vs. control). All subjects underwent oral administration (Ialuril® Soft Gels or placebo) starting one week before the first weekly instillation and ending 30 days after the last one, subsequently starting one week before each monthly instillation and ending 14 days after it. International prostate symptom score (IPSS) and 0-100 visual analogue scale (VAS) were used to assess the efficacy of the treatment. Adverse events were also described. Patients were evaluated at baseline and after 1, 4, 7, and 13 months of intravesical chemotherapy. A total of 34 patients were enrolled. The median IPSS score was significantly lower in the intervention group compared to the control group at 4 (13 vs. 17 points; p = 0.038), 7 (10 vs. 18 points; p < 0.001), and 13 (10 vs. 17 points; p = 0.002) months. The median VAS score was significantly lower in the intervention group compared to the control group at 7 (22 vs. 37 points; p = 0.021) and 13 (20 vs. 35 points; p = 0.024) months. No AE specifically related to supplement or placebo was recorded. Oral formulation of HA, CS, quercetin, and curcumin could be an effective and safe supportive therapy against chemical cystitis in patients receiving intravesical chemotherapy for BCa. 相似文献
995.
Raffaele Vitiello Maria Rosaria Matrangolo Alessandro El Motassime Andrea Perna Luigi Cianni Giulio Maccauro Antonio Ziranu 《Current oncology (Toronto, Ont.)》2022,29(7):4566
Bone can be affected by different neoplastic conditions. Limb salvage surgery has become the preferred treatment strategy for most malignant tumors of the extremities. Advanced 3D printing technology has transformed the conventional view of oncological surgery. These types of implants are produced by electron beam melting (EBM) technology by sintering titanium powder in a scaffold shape designed following a project designed from HRCT and MRI. The aim of our study was to evaluate the outcomes and the mid-term follow-up of a population treated with 3D-printed custom-made prosthesis implantation in major oncological bone resection or after failure of primary implants. The primary outcome was the general patient satisfaction one year after surgery. The secondary outcomes were: mortality rate, treatment related complication rate, functional and clinical outcomes (KPS, ADL and IADL). Eight patients were included, five females and two males, with a mean age of 50.3 (±23.72) years at the surgery. The enrolled patients reported a mean satisfaction rate after surgery of 7.38 (±2) where 10 was the maximum value. There were no changes between pre- and postoperative mean KPS (81.43 +/−10.69). Mean preoperative ADL and IADL score was in both cases 4.86 (±1.07), while postoperative was 5 (±0.82), with a delta of 0.13 (p > 0.05). Custom-made prosthesis permits reconstructing bone defects caused by large tumor resection, especially in anatomically complex areas, restoring articular function. 相似文献
996.
997.
Antonello D'Andrea M.D. Ph.D. Anna Stanziola M.D. Enza Di Palma M.D. Maria Martino M.D. Michele D'Alto M.D. Santo Dellegrottaglie M.D. Rosangela Cocchia M.D. Lucia Riegler M.D. Meredyth Vanessa Betancourt Cordido M.D. Maurizia Lanza M.D. Marco Maglione M.D. Veronica Diana M.D. Raffaele Calabrò M.D. Maria Giovanna Russo M.D. Mani Vannan M.D. Eduardo Bossone M.D. Ph.D. 《Echocardiography (Mount Kisco, N.Y.)》2016,33(1):57-65
998.
Chelation efficacy and erythroid response during deferasirox treatment in patients with myeloproliferative neoplasms in fibrotic phase 下载免费PDF全文
Roberto Latagliata Chiara Montagna Raffaele Porrini Ambra Di Veroli Sabrina Crescenzi Leonetti Pasquale Niscola Fabrizio Ciccone Antonio Spadea Massimo Breccia Luca Maurillo Angela Rago Francesca Spirito Michele Cedrone Marianna De Muro Marco Montanaro Alessandro Andriani Antonino Bagnato Enrico Montefusco Giuliana Alimena 《European journal of haematology》2016,96(6):643-649
At present, very few data are available on deferasirox (DFX) in the treatment of patients with Philadelphia‐negative myeloproliferative neoplasms in fibrotic phase (FP‐MPN) and transfusion dependence. To address this issue, a retrospective analysis of 28 patients (22 male and 6 female) with FP‐MPN and iron overload secondary to transfusion dependence was performed, based on patients enrolled in the database of our regional cooperative group who received treatment with DFX. DFX was started after a median interval from diagnosis of 12.8 months (IR 7.1–43.1) with median ferritin values of 1415 ng/mL (IR 1168–1768). Extra‐hematological toxicity was reported in 16 of 28 patients (57.1%), but only two patients discontinued treatment due to toxicity. Among 26 patients evaluable for response (≥6 months of treatment), after a median treatment period of 15.4 months (IR 8.1–22.3), 11 patients (42.3%) achieved a stable and consistent reduction in ferritin levels <1000 ng/mL. As for hematological improvement, 6 of 26 patients (23%) showed a persistent (>3 months) rise of Hb levels >1.5 g/dL, with disappearance of transfusion dependence in four cases. Treatment with DFX is feasible and effective in FP‐MPN with iron overload. Moreover, in this setting, an erythroid response can occur in a significant proportion of patients. 相似文献
999.
1000.
Raffaele Califano Keith Kerr Robert David Morgan Giuseppe Lo Russo Marina Garassino Floriana Morgillo Antonio Rossi 《Current oncology reports》2016,18(9):59
Despite better understanding of it’s molecular biology, non-small cell lung cancer (NSCLC) remains a challenging disease to treat. Unfortunately, treatment options are still very limited and prognosis for advanced disease is poor. Immune surveillance plays a crucial role in a host’s defence against tumour cells, and this is particular relevant for lung cancer due to it’s high somatic mutational load, which increases the chances for the immune system to recognize cancer cells as ‘non-self’. Novel immunotherapies are emerging as an effective treatment for this disease. In this review, we present the data on immune checkpoint inhibitors for NSCLC, describing their mechanism of action, data efficacy from recent clinical trials, and strategies to select patients more likely to benefit from these agents. 相似文献